Karolina Kauppi

Stockholm, AB 17177, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Pathway-based polygenic risk of Alzheimer's disease highlights immune genes in cognitive decline.

Pathway-based polygenic risk of Alzheimer's disease highlights immune genes in cognitive decline.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: October 07, 2025

Correction: Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.

Correction: Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.

Journal: Alzheimer's research & therapy

Published: February 16, 2024

Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer's Disease.

Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: July 02, 2023

Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging.

Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging.

Journal: Neurobiology of aging

Published: November 14, 2022

APOE ɛ4, but not polygenic Alzheimer's disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals.

APOE ɛ4, but not polygenic Alzheimer's disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals.

Journal: Scientific reports

Published: October 12, 2022

Candidates for drug repurposing to address the cognitive symptoms in schizophrenia.

Candidates for drug repurposing to address the cognitive symptoms in schizophrenia.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: March 10, 2022

Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioning.

Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioning.

Journal: Pharmacoepidemiology and drug safety

Published: January 19, 2022

Polygenic Risk for Schizophrenia Has Sex-Specific Effects on Brain Activity during Memory Processing in Healthy Individuals.

Polygenic Risk for Schizophrenia Has Sex-Specific Effects on Brain Activity during Memory Processing in Healthy Individuals.

Journal: Genes

Published: January 13, 2022

Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals.

Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals.

Journal: Translational psychiatry

Published: June 29, 2021

Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.

Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.

Journal: Alzheimer's research & therapy

Published: April 16, 2021

Short Leukocyte Telomeres, But Not Telomere Attrition Rates, Predict Memory Decline in the 20-Year Longitudinal Betula Study.

Short Leukocyte Telomeres, But Not Telomere Attrition Rates, Predict Memory Decline in the 20-Year Longitudinal Betula Study.

Journal: The journals of gerontology. Series A, Biological sciences and medical sciences

Published: July 06, 2020

Biological and environmental predictors of heterogeneity in neurocognitive ageing: Evidence from Betula and other longitudinal studies.

Biological and environmental predictors of heterogeneity in neurocognitive ageing: Evidence from Betula and other longitudinal studies.

Journal: Ageing research reviews

Published: June 29, 2020

Showing 1-12 of 37

Last Updated: 09/26/2026